PMID: 6159910Oct 1, 1980Paper

Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring

British Journal of Cancer
D R NorfolkA M Ward

Abstract

In a longitudinal study of the evolution of serum beta 2-microglobulin (beta 2-m) levels in 37 patients with myelomatosis, those patients with a level of < 4 mg/l at first presentation had a median survival of 46 months, whereas those with an initial level of > mg/l had a median survival of 15 months. THe beta 2-m appeared to be independent of the level of the paraprotein and its class, as seen in a vertical study of 129 patients. Analysis of the influence of a rising serum creatinine on the serum beta 2-m indicates that beta 2-m production is excessive in advanced disease with or without renal failure. Practical application of the measurement of serum beta 2-m in the stratification and monitoring of patients is suggested.

Citations

Aug 1, 1987·European Journal of Clinical Investigation·B SimonssonA Ahre
Jun 15, 1983·Cancer·H HagbergB Simonsson
Sep 1, 1993·AIDS Research and Human Retroviruses·N C BriggsS Iacobelli
Oct 16, 1999·British Journal of Haematology·F PerosaF Dammacco
Mar 6, 2003·Reviews in Clinical and Experimental Hematology·Jean-Luc Harousseau
Feb 1, 2003·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Cristiano A F ZerbiniMartha Skinner
Nov 26, 2019·European Journal of Haematology·Vanessa PfahlerAndrea Baur-Melnyk
Dec 1, 1985·American Journal of Hematology·R AlexanianH Fritsche
Sep 24, 2014·AJR. American Journal of Roentgenology·Melvin D'AnastasiAndrea Baur-Melnyk
Jan 1, 1989·European Journal of Haematology. Supplementum·G MerliniE Ascari
Dec 1, 1994·British Journal of Haematology·J A Child
Aug 1, 1990·British Journal of Haematology·J CuzickI C MacLennan
Jan 1, 1997·Cancer Investigation·M M Oken
Dec 1, 1983·British Journal of Haematology·M CavoS Tura
Jul 25, 2003·British Journal of Haematology·Joth L JacobsonUNKNOWN Southwest Oncology Group
May 1, 1988·British Journal of Haematology·B SimonssonR Bergström
Oct 1, 1985·British Journal of Haematology·B SimonssonJ S Gronowitz
Mar 28, 1981·British Medical Journal
Oct 1, 1984·Hematological Oncology·J A Child, M R Kushwaha
Nov 1, 1984·Annals of Clinical Biochemistry·J T Whicher
Aug 1, 1983·European Journal of Cancer & Clinical Oncology·R BatailleJ Sany
Oct 1, 1983·European Journal of Cancer & Clinical Oncology·J H ScarffeD Crowther

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Cancer
S H SørensenI C MacLennan
Clinica Chimica Acta; International Journal of Clinical Chemistry
W EngströmP Wahrgren
© 2021 Meta ULC. All rights reserved